Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

68.36 +0.65 (+0.96%)
Official Closing Price Updated: 7:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,207,619
Open 67.46
Bid (Size) 68.04 (1)
Ask (Size) 68.89 (1)
Prev. Close 67.71
Today's Range 67.08 - 68.59
52wk Range 60.57 - 94.87
Shares Outstanding 606,500,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 2
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Nov. 27 through Dec. 1. 
Via Talk Markets
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years
Via Benzinga

Performance

YTD
-7.96%
-7.96%
1 Month
+4.32%
+4.32%
3 Month
-10.02%
-10.02%
6 Month
-25.12%
-25.12%
1 Year
-10.70%
-10.70%

More News

Read More
Peering Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
Analyst Expectations for Edwards Lifesciences's Future
Via Benzinga
Zscaler Posts Q1 Results, Joins argenx, Cool Company And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Could Ozempic Harm These 3 Medical Device Stocks?
Via The Motley Fool
$100 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Here's How Much $100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth Today
Via Benzinga
Jim Cramer Says This Tech Stock Up More Than 60% In 2023 Is An 'Expensive Stock, But It Is A Good One'
Via Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
Via Investor's Business Daily
Why Edwards Lifesciences Stock Plummeted Today
Via The Motley Fool
Earnings Scheduled For October 25, 2023
Via Benzinga
How Is The Market Feeling About Edwards Lifesciences?
Via Benzinga
P/E Ratio Insights for Edwards Lifesciences
Via Benzinga
How Is The Market Feeling About Edwards Lifesciences?
Via Benzinga
Expert Ratings for Edwards Lifesciences
Via Benzinga
US Stocks Poised For Mixed Start Ahead Of Meta Earnings: Analyst Sees Corporate Profits Providing 'Fundamental Ballast' To Market
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
Via Benzinga
Edwards Lifesciences Faces European Scrutiny Over Patent Policies, Copycat Devices
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market?
Via Benzinga
Topics Stocks
Exposures US Equities
Here's How Much $100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today
Via Benzinga
Edwards Lifesciences Commits to Fair Competition Amid Regulatory Scrutiny, Analyst Upgrades Stock
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.